Principal Investigator(s): United States Department of Health and Human Services. National Institutes of Health. National Institute on Drug Abuse
The NIDA Genetics Consortium was created in 1999 and has several overarching missions: (1) identify human chromosomal regions containing genes and/or specific genes that confer susceptibility to drug addiction; (2) create a repository for data (i.e., clinical information and biospecimens containing DNA; (3) generate a database on molecular genetics of drug use disorders and related phenotypes to provide controlled access to collaborative studies with the broader scientific community; and (4) establish a consortium of scientists who meet regularly and collaborate on projects.
Along with the description of the NIDA Genetics Consortium, the Web site outlines policies for access and distribution of DNA and clinical data from NIDA-funded studies on the genetics of addiction vulnerability.
These data are not available from ICPSR. Users should consult the data owners directly (via NIDA Genetics Consortium) for details on obtaining the data and documentation.